Table 3.

Donor T Cells Mediate the Graft Facilitating Activity of Irradiated Allogeneic Splenocytes

BM + Irrad Spleen BM + TCD Irrad Spleen BM Alone
Fraction surviving  11/18  7/10  18/18 
Fraction donor engrafted   9/11  2/7    6/18 
    PValues  
    Irrad Sp v TCD Irrad Sp  Irrad Sp v BM  
% Donor cells 100 ± 42  5 ± 48  0 ± 48  P = .042 P = .025  
T cells  
 % Donor BM  100 ± 42 13 ± 32  0 ± 47  P = .021 P = .023  
 % Donor spleen  0 ± 10 0 ± 0  0 ± 1  
 % Host  0 ± 40 88 ± 36  100 ± 47  P = .030 P = .018 
BM + Irrad Spleen BM + TCD Irrad Spleen BM Alone
Fraction surviving  11/18  7/10  18/18 
Fraction donor engrafted   9/11  2/7    6/18 
    PValues  
    Irrad Sp v TCD Irrad Sp  Irrad Sp v BM  
% Donor cells 100 ± 42  5 ± 48  0 ± 48  P = .042 P = .025  
T cells  
 % Donor BM  100 ± 42 13 ± 32  0 ± 47  P = .021 P = .023  
 % Donor spleen  0 ± 10 0 ± 0  0 ± 1  
 % Host  0 ± 40 88 ± 36  100 ± 47  P = .030 P = .018 

B10.BR mice received 11 Gy irradiation on day −2 and were then transplanted with 1 × 106 BM cells from C57.BL6 mice, or a combination of BM and 75 × 106 irradiated (7.5 Gy) C57.BL6 splenocytes or BM and 60 × 106 TCD irradiated (7.5 Gy) C57.BL6 splenocytes. The C57.BL6 donor mice were all CD45.1+; BM and spleen donors varied according to their expression of Thy 1.1 (spleen) or Thy 1.2 (BM). The median percentages of peripheral blood cells that were donor-derived (CD45.1+) and the percentage of blood T cells that were derived from donor BM, donor spleen, or were of host origin were determined at day +60 to day +70 by flow cytometry.

or Create an Account

Close Modal
Close Modal